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The tumour suppressor p53 is a multifunctional phospho-
protein able to induce apoptosis, di¡erentiation or growth
arrest, by acting as a transcription factor (capable of recog-
nising DNA speci¢c sequences) and targeting expression of
genes involved in cell cycle control [1,2]. p53 is a member of
a family of related proteins (p63/CUSP/KET/p51/p40 and
p73) characterised by multiple isoforms which share similar
biological functions [3^7]. Recently, we have shown that p53
binds to trk A (the receptor for nerve growth factor (NGF))
in the presence of the non-receptor tyrosine kinase c-abl [8,9].
Importantly, p53 induces trk A hyperphosphorylation and
stimulation of signalling cascades in the absence of NGF
stimulation [8^10]. Therefore, because of its role in trk A
signalling, the aim has been to determine whether p53 has
sequence homology to proteins involved in signal transduction
pathways.
From results obtained after a scan of the human p53 se-
quence for the presence of known motifs and, more speci¢-
cally, domains common to signalling proteins using the pro-
gram GAP from the GCG package (Wisconsin Package
Version 9.1, Genetics Computer Group, Madison WI,
USA), it was noticed that p53 and c-Akt had sequence sim-
ilarity. Then the p53 and c-Akt sequences were compared
using a Gibbs sampler approach [11] as implemented in the
program MACAW [12]. The search parameters were: mini-
mum pattern length 4, maximum pattern length 20, random
seed 12345, number of trials six, iterations per 50. The scoring
matrix was BLOSUM62. The comparison revealed two re-
gions of similarity, D1 and D2, with segment-pair scores of
1193 and 1353, and a P value (for each domain) of less than
10320 respectively; thus indicating that the relationship was
signi¢cant. To detect other proteins containing these motifs,
D1 or D2 of the human p53 sequence were subsequently used
as input to a FASTA database search [13]. The FASTA
search was performed using the BLOSUM50 matrix and a
k-tuple value of 2. However, despite the MACAW results,
this search showed that the presence of either motif alone
was not highly signi¢cant. This result was expected as D1
and D2 are short peptide regions. Thus, the possibility of
proteins containing both motifs was investigated with a low-
stringency search using the FINDPATTERNS program of the
GCG package. The sequence pattern syntax covered both D1
and D2 and was £exible enough to allow detection of related
homologues (see Fig. 1). Results revealed that the combined
presence of D1 and D2 is a feature of the p53, 14-3-3 and
Akt/PKB/RAC protein families. The database used was a
non-redundant protein sequence dataset compiled from all
existing public protein databases to date.
Fig. 1A shows the consensus amino acid sequence homol-
ogy of representative members of the p53 family of proteins
with representative members of the 14-3-3 and Akt/PKB/RAC
families respectively. D1 and D2 are separated by a non-ho-
mologous linker region, but in the case of 14-3-3 proteins the
order of these domains is reversed (Fig. 1B). This is the ¢rst
analysis showing shared amino acid sequences between these
families.
The transactivation domain, DNA binding core and car-
boxyl-terminus of human p53 lie within amino acid residues
1^43, 100^300 and 301^393 respectively. D1 and D2 are lo-
cated in the DNA binding core of the p53 family, with D1 in
the C-terminus of conserved region II, a region prone to
germline mutations [14], and D2 proximal to conserved region
III. Importantly, the spatial arrangement of D1 and D2 in the
crystal structure of DNA-bound p53 shows these regions not
bound to DNA and accessible to protein^protein interactions
(Fig. 1C, upper panels) [15].
Heat shock proteins/molecular chaperones (HSPs) have sev-
eral functions; these include stabilisation of newly synthesised
peptides, translocation of peptide chains across membranes
and assisting assembly or disassembly of multimeric com-
plexes [16,17]. Members of the HSP70 family of molecular
chaperones such as Hsc70 and HSP90 have been shown to
associate with mutant rather than wild type p53 [18^20]. How-
ever, more recently, when experiments were carried out using
a library of wild type p53 overlapping peptides, it was shown
that sequences of the DNA core domain were able to bind
Hsc70 and peptides containing D1 and D2 bound with high
a⁄nity [21]. These data suggest that the biological function of
D1 and D2 is to mediate p53 and Hsc70 association.
Akt/PKB/RAC proteins are cytoplasmic serine/threonine
kinases and direct targets of growth factor or insulin-activated
phosphatidylinositol (PI)-3 kinase [22,23]. These proteins con-
tain an amino-terminal pleckstrin homology (PH) domain and
a catalytic kinase domain (residues 1^109 and 148^411 respec-
tively) linked by a highly acidic region (residues 110^147). The
PH domain of Akt is involved in protein interactions and
phospholipid binding [24]. Crystallographic data of the PH
domain from pleckstrin N show this domain exposed within
the molecule [25]. In Akt D1 is located in the C-terminus of
the PH domain and D2 in the C-terminus of the acidic linker.
Unfortunately, the crystal structure of Akt has not been
solved; thus, it is not possible to de¢ne the spatial arrange-
ment of D1 and D2 in this protein. There is evidence showing
that growth factor regulation of Akt can be PI-3 kinase-de-
pendent or -independent [22,26]. Proteins such as v-src and
sevenless are regulated by associating to a complex of cdc37
and HSP90 [27]. These complexes seem to act as general chap-
erones for protein kinases [27]. Interestingly, there is evidence
suggesting that Akt is also regulated by this process and that
it can directly bind to HSP90 [26,28]. Importantly, the pres-
ence of D1 and D2 suggests that Hsc70 could potentially
associate and be involved in Akt regulation.
14-3-3 proteins are a family of highly conserved molecules.
They can regulate and interact with phosphoserine containing
proteins known to participate in signalling pathways involved
in the control of cell proliferation, di¡erentiation and trans-
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formation [29,30]. The monomer contains nine K-helices and
regions with homology to the PKC pseudosubstrate and an-
nexin respectively (amino acids 53^56 and 122^136 in 14-3-
3j). The crystal structure was solved as a dimer revealing an
amphipathic groove that mediates c-raf binding [30,31]. Spa-
tial analysis of 14-3-3j shows D1 and D2 adjacent to this
groove (Fig. 1C, lower left panel). Although amino acids
from this groove are directly involved in several protein inter-
actions, there is evidence that residues spanning amino acids
171^213 (termed box 1) can participate in protein^protein
associations [30,32^34]. For example, a sequence containing
D2 (amino acids 163^187) contributes to c-raf recognition [33]
(Fig. 1C, lower right panel). Proteins such as platelet glyco-
protein 1bx bind to a region containing D1 (amino acids 188^
209) [33] and tryptophan hydroxylase can associate with the
box 1 region which contains both D1 and D2 [34]. Impor-
tantly, computer analysis shows that D1 and D2 are greatly
conserved among all members of the family, suggesting that
both motifs, in all 14-3-3 proteins, appear to be involved in
protein^protein interactions. To date there is no evidence
showing 14-3-3 binding to HSP70 members, but the presence
of these motifs suggests that it is possible that HSP70 mole-
cules could compete for binding with, for example, the above
proteins at the D1 and D2 sites.
In conclusion these data show that there are two regions
within members of p53, 14-3-3 and Akt protein families which
may be evolutionarily conserved. Their presence possibly
leads to a common biological function such as regulation
and binding to heat shock chaperones.
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Fig. 1. Multiple sequence alignment of representative members of p53, 14-3-3 and Akt families. A: Alignment showing amino acid residues of
D1 and D2. Because of the large number of proteins belonging to each family, especially 14-3-3, only a set of representative members are de-
picted. D1 and D2 were aligned using the MACAW multiple sequence alignment program [12]. All conserved residues are shown in orange. In
D1 A at position 4 is conserved between p53 and 14-3-3 families and T at position 6 is conserved in p53 and Akt members (shown in yellow).
All proteins with exception of 14-3-3j and Rad24 have Q at position 2 (shown in yellow) which is replaced by S and Y respectively (shown in
white). Interestingly, comparative analyses of all 14-3-3 family members to date show high amino acid variability at D1 position 2 containing
residues N, H, S, Q, L, T, G, H, D or Y (from which N is the most prevalent and Y is the least common) and low variability at amino acid
position 6 containing either Q or T (of which Q is the most prevalent) (data not shown). In D2 I at position 6 is conserved between members
of p53 and 14-3-3 and V at position 8 is conserved between members of p53 and Akt (shown in yellow) whereas R at position 7 is conserved
between members of p53, 14-3-3 and Akt (shown in orange) but is replaced by K in chicken c-Akt (shown in yellow). Comparative analyses of
all v- and c-Akt members to date showed only chicken c-Akt containing K at position 8. L and P at position 5 are conserved within the p53
and 14-3-3 families respectively (shown in yellow and white). P at position 2 is conserved in all p53 proteins and in members of p63 (shown in
white), but not in p73K and L in which it is replaced by A. T and K at position 3 are conserved within 14-3-3 and Akt families respectively
(shown in white). Q at position 3 is conserved within p53 proteins and S is conserved within members of p63 and p73. Importantly, compara-
tive analysis of all 14-3-3 proteins to date shows D2 containing the same amino acid sequences in all members of the family. The pattern for
FINDPATTERNS of the GCG program used for the searches is :
CxL; IA;MKT;QUf15; 75gPxf0; 2gHxf0; 2gR;KV; I;L
Pxf0; 2gHxf0; 2gR;KV; I;LUf15; 75gCxL; IA;MK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The Ensembl project (http://www.ensembl.org/; [35]) produces automated annotation of the publicly available human genomic sequence data
by using gene prediction software and a variety of analytical tools. The predictions are split into con¢rmed and predicted genes (and their
translated products) on the basis of supporting evidence from similarity to known ESTs, genes and proteins in the public sequence databases.
The predicted and con¢rmed protein datasets were also used (as already described) to detect D1 and D2. Interestingly, results showed that in
both the predicted as well as in the con¢rmed sets D1 and D2 were present in 14-3-3 as well as p53 and p73K and L members. The presence
of c-Akt was not seen in current searches; this is probably due to the lack of data, to date, available from the Ensembl project; this most
likely will be obtainable in the future while progress of the human genome analysis is made. Accession numbers: human p53 P04637; mouse
p53 P02340; human p73K,L 015350; human p63K, L and Q AAC62635, AAC62637, AAC62633; human 14-3-3j P29312; Drosophila 14-3-3j
P29310; Schizosaccharomyces pombe Rad24 P42656; v-Akt P31748; human c-Akt P31749; chicken c-Akt AAB94767. B: Schematic representa-
tion of D1 (blue) and D2 (green). C: Stereoview of the spatial arrangement of D1 (red) and D2 (blue) showing two di¡erent orientations in
DNA (green)-bound p53 (upper panels) and in 14-3-3j- or raf (yellow)-bound 14-3-3j (lower panels) using Rasmol software. PDB identi¢er
numbers: DNA-bound p53: 1TSR; 14-3-3j dimer: 1A40; raf-bound 14-3-3j : 1A37.
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